SEC Form 4 · accession 0001209191-17-049038
SANGAMO THERAPEUTICS, INC · SGMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Curt A. Herberts III
Officer — Sr.VP & Chief Business Officer
Period of report
Aug 11, 2017
Accepted (ET)
Aug 15, 2017 · 5:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 11, 2017 | M | 3,474 | $3.99 | A | 23,991 | D | |
| Common Stock | Aug 11, 2017 | M | 3,000 | $2.55 | A | 26,991 | D | |
| Common Stock | Aug 11, 2017 | S | 6,474 | $10.00 | D | 20,517 | D | |
| Common Stock | Aug 14, 2017 | M | 5,000 | $5.12 | A | 25,517 | D | |
| Common Stock | Aug 14, 2017 | S | 5,000 | $11.00 | D | 20,517 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $3.99 | Aug 11, 2017 | M | 3,474 | D | — | Oct 17, 2020 | Common Stock | 3,474 | 0 | D |
| Stock Option (Right to Buy)F2 | $2.55 | Aug 11, 2017 | M | 3,000 | D | — | Dec 27, 2021 | Common Stock | 3,000 | 0 | D |
| Stock Option (Right to Buy)F2 | $5.12 | Aug 14, 2017 | M | 5,000 | D | — | Aug 31, 2021 | Common Stock | 5,000 | 0 | D |
Explanation of responses
- F1All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017.
- F2The shares underlying the stock option are fully vested and exercisable.